Dana Vanderwall

Dana Vanderwall is an innovative leader in scientific solutions for drug discovery and digital transformation with over 25 years of experience in Pharmaceutical/Biopharma R&D.  He has experience in biochemistry, structural biology, computational chemistry, cheminformatics, IT and data strategy, and product management for enterprise informatics software. Dana’s experience in industry collaborations and data standards includes: Board Chair of Allotrope Foundation; a Fellow of the Society for Laboratory Automation and Screening and member Data Standards Comittee; contributions to projects within the Pistoia Alliance; member of IUPAC Committee on Publications and Cheminformatics Data Standards and Chair of the IUPAC Subcommittee on HELM.   

Dana holds a B.S. in Biochemistry from the University of Wisconsin, Madison and a Ph.D. from the University of Maryland College Park and is a member of the Business Architecture Guild and DAMA International.